Clinical Trials Directory

Trials / Conditions / Stage IIIC Ovarian Cancer AJCC v6 and v7

Stage IIIC Ovarian Cancer AJCC v6 and v7

16 registered clinical trials studyying Stage IIIC Ovarian Cancer AJCC v6 and v7.

StatusTrialSponsorPhase
WithdrawnWeb-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With
NCT03902379
Rutgers, The State University of New JerseyN/A
Active Not RecruitingMatched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontl
NCT02726997
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedPembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal,
NCT02520154
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingAdavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary P
NCT02659241
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedTalazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tu
NCT02316834
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedEpacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopia
NCT02042430
National Cancer Institute (NCI)EARLY_Phase 1
Active Not RecruitingTORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid T
NCT02142803
National Cancer Institute (NCI)Phase 1
Active Not RecruitingSurgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopi
NCT01970722
City of Hope Medical CenterPhase 1
UnknownDiet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo
NCT00719303
Gynecologic Oncology GroupPhase 3
CompletedPropranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian
NCT01504126
M.D. Anderson Cancer CenterEARLY_Phase 1
Active Not RecruitingCarboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy i
NCT01081262
National Cancer Institute (NCI)Phase 3
Active Not RecruitingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage
NCT01167712
National Cancer Institute (NCI)Phase 3
CompletedCarboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovar
NCT00989651
National Cancer Institute (NCI)Phase 1
UnknownPaclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Ut
NCT00954174
GOG FoundationPhase 3
CompletedBevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epi
NCT00951496
National Cancer Institute (NCI)Phase 3
UnknownPaclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian E
NCT00108745
GOG FoundationPhase 3